Pharmaceutical

Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate…

10 months ago

Abzena Strengthens Executive Leadership Team with the Appointment of Taylor Boyd as CBO

SAN DIEGO, Calif., Feb. 26, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and…

10 months ago

Avance Biosciences™ Registers with CLIA, Expanding Clinical Trial Testing Capabilities

HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical…

10 months ago

LSPedia Awarded MMCAP Infuse National Contract for FDA DSCSA Compliance

LSPedia's OneScan Suite Transforms Healthcare Operations with Seamless FDA DSCSA Compliance, Integration, and Unmatched Supply Chain Insights. FARMINGTON HILLS, Mich.,…

10 months ago

Compugen Enhances its AI/ML Predictive Computational Discovery Platform, Unigen™ with Ultima Genomics’ Single Cell Genomics Sequencing Technology

Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigen™ with Ultima's UG 100™ sequencing platform to better understand…

10 months ago

LiveWorld Expands Board of Directors, Adding Healthcare & Tech Executive Carl Gustin

Marketing innovator Mr. Gustin to drive LiveWorld’s AI-powered growth Carl Gustin, Chief Strategy & Marketing Officer, SpeciCare Carl Gustin appointed…

10 months ago

Rakovina Therapeutics and Variational AI Strengthen Partnership

Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered CollaborationsVANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE…

10 months ago

Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives

DURHAM, N.C., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated…

10 months ago

Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality”

HOUSTON, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering,…

10 months ago